392 related articles for article (PubMed ID: 14509690)
1. Dystonia and headaches: clinical features and response to botulinum toxin therapy.
Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR
Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690
[No Abstract] [Full Text] [Related]
2. [Botulinum: fashionable drug and effective medication. What the "miracle weapon against crow's feet" can do in addition].
Stiefelhagen P
MMW Fortschr Med; 2003 Apr; 145(14):4-6. PubMed ID: 15072266
[No Abstract] [Full Text] [Related]
3. Botulinum toxin in cervical dystonia.
Tsui JK; Calne DB
Adv Neurol; 1988; 49():473-8. PubMed ID: 3344637
[No Abstract] [Full Text] [Related]
4. A new botulinum toxin (Xeomin) for cervical dystonia and blepharospasm.
Med Lett Drugs Ther; 2010 Nov; 52(1351):90-1. PubMed ID: 21068703
[TBL] [Abstract][Full Text] [Related]
5. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
Brin MF; Fahn S; Moskowitz C; Friedman A; Shale HM; Greene PE; Blitzer A; List T; Lange D; Lovelace RE
Adv Neurol; 1988; 50():599-608. PubMed ID: 3400513
[No Abstract] [Full Text] [Related]
6. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
7. [Botulinum toxin. Development for therapeutic purposes].
Ceballos-Baumann A
Nervenarzt; 2008 Jun; 79 Suppl 1():3-8. PubMed ID: 18927957
[TBL] [Abstract][Full Text] [Related]
8. [Clinical use of botulinum toxin].
Jost WH
Nervenarzt; 2008 Jun; 79 Suppl 1():9-14. PubMed ID: 18927958
[TBL] [Abstract][Full Text] [Related]
9. The effects of botulinum toxin on ocular tissue.
Smith H
Nurs Times; 1995 Jan 25-31; 91(4):41-3. PubMed ID: 7862573
[TBL] [Abstract][Full Text] [Related]
10. Autonomic side effects of botulinum toxin type B therapy.
Dressler D; Benecke R
Adv Neurol; 2004; 94():315-20. PubMed ID: 14509689
[No Abstract] [Full Text] [Related]
11. Blepharospasm and oromandibular-laryngeal-cervical dystonia: a controlled trial of botulinum A toxin therapy.
Jankovic J
Adv Neurol; 1988; 50():583-91. PubMed ID: 3041763
[No Abstract] [Full Text] [Related]
12. Botulinum toxin treatment of axial and cervical dystonia.
Benecke R; Dressler D
Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
Pappert EJ; Germanson T;
Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
[TBL] [Abstract][Full Text] [Related]
14. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
Bihari K
Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
[TBL] [Abstract][Full Text] [Related]
15. Distant effects of local injection of botulinum toxin.
Lange DJ; Brin MF; Warner CL; Fahn S; Lovelace RE
Muscle Nerve; 1987; 10(6):552-5. PubMed ID: 3455658
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group.
Berardelli A; Formica A; Mercuri B; Abbruzzese G; Agnoli A; Agostino R; Caraceni T; Carella F; De Fazio G; De Grandis D
Ital J Neurol Sci; 1993 Jun; 14(5):361-7. PubMed ID: 8354632
[TBL] [Abstract][Full Text] [Related]
17. [Current status and prospects of medical therapy for dystonia].
Osawa M
Rinsho Shinkeigaku; 2006 Nov; 46(11):967-9. PubMed ID: 17432235
[TBL] [Abstract][Full Text] [Related]
18. [Indications for botulinum toxin in neurology].
Ghika J; Küntzer T; Regli F
Rev Med Suisse Romande; 1994 Jun; 114(6):551-5. PubMed ID: 8047771
[No Abstract] [Full Text] [Related]
19. Natural history of posttraumatic cervical dystonia.
Frei KP; Pathak M; Jenkins S; Truong DD
Mov Disord; 2004 Dec; 19(12):1492-8. PubMed ID: 15390063
[TBL] [Abstract][Full Text] [Related]
20. [A case of laryngeal adductor dystonia treated with transcutaneous injections of botulinum toxin].
Zielińska M; Selmaj K
Neurol Neurochir Pol; 1998; 32(5):1273-80. PubMed ID: 10463240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
